Suitability of SSCP-PCR analysis for molecular detection of quinolone resistance in Campylobacter jejuni

被引:0
作者
Beckmann, L
Müller, M
Luber, P
Schrader, C
Bartelt, E
Klein, G
机构
[1] Tierarztlichen Hsch Hannover, Zentrum Lebensmittelwissensch, D-30173 Hannover, Germany
[2] Bundesinst Risikobewertung, Berlin, Germany
来源
BERLINER UND MUNCHENER TIERARZTLICHE WOCHENSCHRIFT | 2003年 / 116卷 / 11-12期
关键词
Campylobacter jejuni; SSCP-PCR; quinolone resistance; QRDR;
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Foodborne infections with Campylobacter spp. are increasing, especially antibiotic resistant strains are emerging. Quinolone resistant isolates can cause failure of therapy in severe clinical infections. Molecular characterisation is needed for the detection of resistant variants of C. jejuni. Therefore 23 isolates from poultry and human medicine as well as three control strains were tested for their minimal inhibitory concentration, their Single-Strand-Conformation-Polymorphism (SSCP)-PCR pattern (a method for the detection of resistance determining point mutations), and their sequence of the quinolone resistance determining region (QRDR). Six differnt SSCP types could be identified: two types for quinolone resistant isolates and other types containing so called silent mutations without influence on the resistance. A genotypic monitoring of the quinolone resistance in C jejuni can be useful for the early detection of new resistance variants. As a screening method for detection of point mutations in the QRDR the SSCP-PCR can be applied. Compared to other genotypic methods the SSCP-PCR is less time and cost consuming and needs only standard technical equipment.
引用
收藏
页码:487 / 490
页数:4
相关论文
共 21 条
  • [1] Single or double mutational alterations of GyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli
    Bachoual, R
    Ouabdesselam, S
    Mory, F
    Lascols, C
    Soussy, CJ
    Tankovic, J
    [J]. MICROBIAL DRUG RESISTANCE, 2001, 7 (03) : 257 - 261
  • [2] BARTELT E, 2003, ARB ARB LEB DTSCH VE, P212
  • [3] *BGVV, 2002, EXP PROBL FLUORCH BA
  • [4] Charvalos E, 1996, J CLIN LAB ANAL, V10, P129, DOI 10.1002/(SICI)1098-2825(1996)10:3<129::AID-JCLA3>3.0.CO
  • [5] 2-6
  • [6] Quinolone and macrolide resistance in Campylobacter jejuni and C-coli:: Resistance mechanisms and trends in human isolates
    Engberg, J
    Aarestrup, FM
    Taylor, DE
    Gerner-Smidt, P
    Nachamkin, I
    [J]. EMERGING INFECTIOUS DISEASES, 2001, 7 (01) : 24 - 34
  • [7] gyrA polymorphism in Campylobacter jejuni:: Detection of gyrA mutations in 162 C-jejuni isolates by single-strand conformation polymorphism and DNA sequencing
    Hakanen, A
    Jalava, J
    Kotilainen, P
    Jousimies-Somer, H
    Siitonen, A
    Huovinen, P
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (08) : 2644 - 2647
  • [8] Emerging mechanisms of fluoroquinolone resistance
    Hooper, DC
    [J]. EMERGING INFECTIOUS DISEASES, 2001, 7 (02) : 337 - 341
  • [9] International Organization for Standardization (ISO), 1995, 102721995 ISO
  • [10] Comparison of broth microdilution, E test, and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni and Campylobacter coli
    Luber, P
    Bartelt, E
    Genschow, E
    Wagner, J
    Hahn, H
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (03) : 1062 - 1068